CD1C and mycosis fungoides: On the other hand, IL-32β and IL-32γ have been shown to accelerate the induction of CD1c+ mDCs and CD163+CD68+ macrophages expressing IDO in MF skin lesions and to contribute to a tolerogenic tumor environment (23).